Topical Urea Treatment Indications
Topical urea is indicated for hyperkeratotic conditions including ichthyosis, psoriasis, xerosis, eczema, keratosis pilaris, palmoplantar keratoderma, corns, calluses, and damaged nails, functioning as both a keratolytic agent (≥10% concentration) and moisturizer (<10% concentration). 1
Primary Indications by Concentration
Lower Concentrations (≤10%)
- Moisturization and hydration for dry, rough skin
- Xerosis (dry skin conditions)
- Atopic dermatitis/eczema maintenance
- General skin barrier support 2, 1
Higher Concentrations (>10%)
- Keratolytic action for scaling and hyperkeratosis
- Congenital ichthyoses (10-40% urea is most commonly used keratolytic) 2
- Psoriasis with significant scaling 1
- Palmoplantar keratoderma (up to 40% for localized thick areas) 2
- Keratosis pilaris (20% formulations show efficacy) 3
- Calluses and corns 1
Specific Clinical Applications
Congenital Ichthyoses
Urea ≥10% demonstrates superiority over emollients alone in removing scales and hyperkeratosis and is the most frequently used keratolytic agent in clinical practice. 2 Concentrations can be increased to 20%, or even 40% for localized areas of thick scale or hyperkeratosis such as joints or palmoplantar regions. Application is typically once or twice daily and can be tapered based on response. 4
Chemotherapy-Induced Skin Reactions
Urea 10% cream applied three times daily is recommended for prevention of hand-foot skin reactions (HFSR) and palmar-plantar erythrodysesthesia syndrome (PPES) in patients receiving MEK inhibitors, capecitabine, doxorubicin, or taxanes. 5 For established grade ≥3 reactions, keratolytic concentrations of 10-40% may be used. 5
Nail Disorders
Indicated for damaged, ingrown, and devitalized nails, as well as adjunctive treatment in onychomycosis. 1, 6
Pruritus and Uremic Xerosis
Effective for pruritus associated with dry skin conditions, including uremic pruritus in hemodialysis patients, where 10% urea formulations significantly reduce both xerosis and itching. 7
Critical Age-Related Contraindications
Urea is relatively contraindicated in the first 6-12 months of life due to epidermal barrier defects, immature stratum corneum, and higher body-surface-to-mass ratio increasing systemic absorption risk. 2 High blood urea concentrations have been reported after cutaneous application of 10% urea (plus 5% lactic acid) in collodion babies and infants with lamellar ichthyosis. 2
Exception: Urea may be used in neonates only on very limited areas such as palms and soles, applied once daily. 4, 2
For children under 2 years, urea ≥10% is not recommended except once daily on limited areas like palms and soles. 4
Application Guidelines
- Frequency: Once to twice daily, typically applied after bathing to improve hydration 4
- Dosing: Can be tapered based on clinical response 4, 2
- Avoid: Face, flexures, and areas of fissuring with higher concentrations due to irritation risk 4
Common Pitfalls
Side effects include itching, burning sensation, and irritation, particularly at higher concentrations and on sensitive areas. 4 These effects are generally mild and concentration-dependent. 8, 9, 6 The burning sensation is more frequent with higher concentrations but products are generally well-tolerated with excellent safety profiles. 3
Combination Therapy
Urea functions as a penetration enhancer, optimizing the action of other topical drugs including corticosteroids, antifungals, and retinoids. 8, 9, 6 It can be used as monotherapy or combined with oral retinoids for congenital ichthyoses. 4